DLBS1033 for Acute NSTEMI Without Early Coronary Revascularization

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
This is a prospective, randomized, double-blind, double-dummy, and controlled study of DLBS1033 in the management of acute non-ST elevation myocardial infarction (NSTEMI) without early coronary revascularization. It is hypothesized that the combination of DLBS1033 with aspirin and clopidogrel will result in greater reduction of infarct size in comparison with that of aspirin and clopidogrel alone.
Epistemonikos ID: c10c977ef918a17c4fd0a17be12a04ef5ee4238f
First added on: May 11, 2024